4826 - 4850 of 8673 Results
Title
Year
- Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasis2021OPENTitle: Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasisJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embj.2020105531Best OA location URL: http://urn.fi/urn:nbn:fi-fe202301316706Citation Count: 23
-
OPENTitle: The neuro-toxin MPTP does not prevent reproduction in marmosetsJournal Name: MNI Open ResearchPublisher: F1000 Research LtdVol: 3Issue #:Start Page: 2End Page: 2Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.12688/mniopenres.12818.2Best OA location URL: https://mniopenresearch.org/articles/3-2/v2/pdfCitation Count: 0
-
OPENTitle: Structure-based design and characterization of Parkin-activating mutationsJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 6Issue #: 6Start Page: e202201419End Page: e202201419Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.26508/lsa.202201419Best OA location URL: https://www.life-science-alliance.org/content/lsa/6/6/e202201419.full.pdfCitation Count: 23
- Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease2019OPENTitle: Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 6Start Page: e0217566End Page: e0217566Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0217566Citation Count: 49
- Evidence for encephalopsin immunoreactivity in interneurones and striosomes of the monkey striatum2018RESTRICTEDTitle: Evidence for encephalopsin immunoreactivity in interneurones and striosomes of the monkey striatumJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 236Issue #: 4Start Page: 955End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00221-018-5191-9Citation Count: 19
- An implantable human stem cell-derived tissue-engineered rostral migratory stream for directed neuronal replacement2021OPENTitle: An implantable human stem cell-derived tissue-engineered rostral migratory stream for directed neuronal replacementJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-021-02392-8Best OA location URL: https://www.nature.com/articles/s42003-021-02392-8.pdfCitation Count: 8
-
RESTRICTEDTitle: Constipation in a Large Online Cohort of Persons with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.70168Citation Count: 1
- Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?2022RESTRICTEDTitle: Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1782End Page: 1782Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29136Citation Count: 0
-
OPENTitle: Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and DiseaseJournal Name: ReceptorsPublisher: MDPI AGVol: 3Issue #: 2Start Page: 155End Page: 181Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/receptors3020009Best OA location URL: https://www.mdpi.com/2813-2564/3/2/9/pdf?version=1712907165Citation Count: 28
- Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug Strategy2018RESTRICTEDTitle: Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug StrategyJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 11Start Page: 2542End Page: 2547Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00236Citation Count: 12
- Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers2015RESTRICTEDTitle: Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriersJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 83Issue #:Start Page: 115End Page: 121Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.08.011Citation Count: 144
- Brain-first forms of Parkinson's disease are over-represented in patients with non-responsive resting tremor2024OPENTitle: Brain-first forms of Parkinson's disease are over-represented in patients with non-responsive resting tremorJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 201Issue #:Start Page: 106691End Page: 106691Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2024.106691Best OA location URL: https://doi.org/10.1016/j.nbd.2024.106691Citation Count: 0
-
OPENTitle: Cheek cell–derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from controlJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 2Start Page: 418End Page: 420Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.08.008Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2013.08.008Citation Count: 30
- Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?2013OPENTitle: Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?Journal Name: Future NeurologyPublisher: Informa UK LimitedVol: 8Issue #: 3Start Page: 321End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/fnl.13.14Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3815586Citation Count: 50
- Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases2023OPENTitle: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseasesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00604-yBest OA location URL: https://doi.org/10.1038/s41531-023-00604-yCitation Count: 38
- Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)2022OPENTitle: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 139End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002Best OA location URL: http://www.prd-journal.com/article/S1353802022002553/pdfCitation Count: 10
- Nutrition effects on brain outcomes and recovery in stroke after hospitalization (NOURISH): Randomized controlled trial protocol and rationale2025RESTRICTEDTitle: Nutrition effects on brain outcomes and recovery in stroke after hospitalization (NOURISH): Randomized controlled trial protocol and rationaleJournal Name: Contemporary Clinical TrialsPublisher: Elsevier BVVol: 158Issue #:Start Page: 108108End Page: 108108Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cct.2025.108108Citation Count: 0
-
RESTRICTEDTitle: Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulationJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 390Issue #:Start Page: 33End Page: 35Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2018.04.002Best OA location URL: https://zenodo.org/records/3873091/files/Main_text_JONS_revised_26_Mar_2018_CLEAN.pdfCitation Count: 2
- Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI Study2017OPENTitle: Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI StudyJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00100Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00100/pdfCitation Count: 15
-
RESTRICTEDTitle: Parkinson's disease motor subtypes and bilateral GPi deep brain stimulation: One-year outcomesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 75Issue #:Start Page: 7End Page: 13Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.004Citation Count: 20
- Identification of small molecule dimethyoxyphenyl piperazine inhibitors of alpha-synuclein fibril growth2025OPENTitle: Identification of small molecule dimethyoxyphenyl piperazine inhibitors of alpha-synuclein fibril growthJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-025-17658-yBest OA location URL: https://www.nature.com/articles/s41598-025-17658-y.pdfCitation Count: 0
-
OPENTitle: Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approachJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 102Issue #:Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.02.001Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.02.001Citation Count: 15
-
RESTRICTEDTitle: Functional ataxia in a specialized ataxia centerJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 120Issue #:Start Page: 106006End Page: 106006Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106006Citation Count: 0
-
OPENTitle: Neuroimmunology of the Interleukins 13 and 4Journal Name: Brain SciencesPublisher: MDPI AGVol: 6Issue #: 2Start Page: 18End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci6020018Best OA location URL: https://www.mdpi.com/2076-3425/6/2/18/pdf?version=1465804812Citation Count: 102
-
OPENTitle: Six Action Steps to Address Global Disparities in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 9Start Page: 929End Page: 929Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1783Citation Count: 95